Vol. 3 — May-June 2012

• Pathogenesis of calcineurin inhibitor–induced hypertension
  

  Ewout J. Hoorn¹, Stephen B. Walsh², James A. McCormick³, Robert Zietse¹, Robert J. Unwin², David H. Ellison³

  (1) Department of Internal Medicine – Nephrology, Erasmus Medical Center, Rotterdam - The Netherlands
  (2) UCL Centre for Nephrology, UCL Medical School, University College London, London - UK
  (3) Division of Hypertension and Nephrology, Oregon Health and Science University, Portland, Oregon - USA

• New therapeutic approaches for resistant hypertension
  

  Guido Grassi^1,2, Giuseppe Mancia¹

  (1) Department of Internal Medicine, S. Gerardo Hospital, Monza, University of Milano-Bicocca, Milan - Italy
  (2) and Multimedica IRCCS, Sesto San Giovanni, Milan - Italy

• Pitfall in nephrology: contrast nephropathy has to be differentiated from renal damage due to atheroembolic disease
  

  Piero Stratta¹, Cristina Bozzola², Marco Quaglia¹

  (1) Division of Nephrology and Urology, Department of Translational Medicine, Amedeo Avogadro University, Novara - Italy
  (2) Division of Pathology, Department of Health Sciences, Amedeo Avogadro University, Novara - Italy

• Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials
  

  Mei Dong¹, Zhanquan Jiao², Tong Liu², Fangming Guo³, Guangping Li²

  (1) Yu Huang Top Hospital of Yantai, Shan Dong Province - PR China
  (2) Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin - PR China
  (3) Yan Tai Shan Hospital of Yantai, Shan Dong Province - PR China

• Challenges to enrollment and randomization of the frequent hemodialysis network (FHN) daily trial
  

  Olga Sergeyeva¹, Irina Gorodetskaya^2,3, Rosio Ramos¹, Brigitte M. Schiller^4,5, Brett Larive⁶, Jochen G. Raimann¹, George O. Ting^4,7, Paul W. Eggers⁸, Glenn M. Chertow^2,3, Nathan W. Levin¹, Frequent Hemodialysis Network Trials Group*⁹

  (1) Renal Research Institute, New York - USA
  (2) Department of Medicine, University of California San Francisco, San Francisco, CA - USA
  (3) and Department of Medicine, Stanford University, Palo Alto, CA - USA
  (4) Department of Medicine, Stanford University, Palo Alto, CA - USA
  (5) and Satellite Healthcare, San Jose, CA - USA
  (6) Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH - USA
  (7) and El Camino Hospital, Mountain View, CA - USA
  (8) Division of Kidney, Urology and Hematology, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD - USA
  (9) * See the Appendix for members of the Frequent Hemodialysis Network Trials Group

• Relationship between glutathione S-transferase M1 polymorphism and clinical outcomes in Chinese peritoneal dialysis pati
  

  Peter Yam-Kau Poon¹, Cheuk-Chun Szeto¹, Bonnie Ching-Ha Kwan¹, Kai-Ming Chow¹, Philip Kam-Tao Li¹

  (1) Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong - China

• Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors
  

  Nisha Bansal¹, Eric Vittinghoff², Laura Plantinga¹, Chi-Yuan Hsu¹

  (1) Department of Medicine, University of California, San Francisco, California - USA
  (2) Department of Epidemiology and Biostatistics, University of California, San Francisco, California - USA

• Awareness of albuminuria in an Italian population-based cohort of patients treated with hypoglycemic drugs
  

  Luca Degli Esposti¹, Stefania Saragoni¹, Stefano Buda¹, Alessandra Sturani², Giuseppe Quintaliani³, Sandra Bartolucci⁴, Roberta Di Turi⁵, Paolo Lilli⁶, Guido Didoni^7,8, Ezio Degli Esposti¹

  (1) CliCon S.r.l. Health, Economics and Outcomes Research, Ravenna - Italy
  (2) General Management Unit, Policlinics Umberto I, Rome - Italy
  (3) Nephrology and Dialysis Unit, Perugia Hospital, Perugia - Italy
  (4) Information Technology Department, Local Health Unit 8, Arezzo - Italy
  (5) Pharmaceutical Department, Local Health Unit Roma A, Rome - Italy
  (6) Pharmaceutical Department, Local Health Unit 3 Umbria, Foligno - Italy
  (7) Health Economics &
  (8) Outcomes Research, Bristol-Myers Squibb, Rome - Italy

• High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary interventi
  

  Yong Liu¹, Ning Tan¹, Ying-Ling Zhou¹, Yu-Yi Chen¹, Ji-Yan Chen¹, Jin Chen¹, Jian-Fang Luo¹

  (1) Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou - PR China

• Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis
  

  Wolfgang C. Winkelmayer^1,2, Jun Liu¹, Amanda R. Patrick¹, Soko Setoguchi^1,3, Niteesh K. Choudhry¹

  (1) Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts - USA
  (2) and Division of Nephrology, Stanford University School of Medicine, Palo Alto, California - USA
  (3) and Duke Clinical Research Institute, Duke University Medical School, Durham, North Carolina - USA

• Effectiveness and safety of extended-release nicotinic acid for reducing serum phosphorus in hemodialysis patients
  

  Pornanong Aramwit¹, Rachanon Srisawadwong¹, Ouppatham Supasyndh²

  (1) Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok - Thailand
  (2) Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok - Thailand

• Evaluation of growth in low-body-weight kidney transplant Egyptian children: 25-year experience
  

  Ahmed Mohammed Mosaad¹, Ahmed Farouk Aziz Hamdy¹, Nabil Mohamed Abd El-Fattah Hassan¹, Ahmed Farouk Donia¹, Osama Gheith¹, Mohamed El-Sayed Salem², El-Metwally Lotfy El-Shahawy², Mohamed Adel Bakr¹, Mohamed Ahmed Ghoneim³

  (1) Nephrology Department, Urology and Nephrology Center, Mansoura University, Mansoura - Egypt
  (2) Nephrology Department, Banha Faculty of Medicine, Banha - Egypt
  (3) Urology Department, Urology and Nephrology Center, Mansoura University, Mansoura - Egypt

• Determinants of bone mineral density in stable kidney transplant recipients
  

  Alok K. Gupta¹, Michael Huang², G.V. Ramesh Prasad^1,2

  (1) Division of Nephrology, University of Toronto, Toronto, Ontario - Canada
  (2) Renal Transplant Program, St. Michael’s Hospital, Toronto, Ontario - Canada

• Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus
  

  Ali Mohsen¹, Rebecca Brown¹, Richard Hoefield^2,3, Philip A. Kalra^2,3, Donal O’Donoghue⁴, Rachel Middleton⁴, David New^2,3

  (1) School of Medicine, The University of Manchester, Manchester - UK
  (2) Department of Renal Medicine, Salford Royal Foundation Trust, Salford, Greater Manchester - UK
  (3) and Vascular Research Group, The University of Manchester, Manchester Academic Health Sciences Centre, Salford Royal Hospital Foundation Trust, Salford, Greater Manchester - UK
  (4) Vascular Research Group, The University of Manchester, Manchester Academic Health Sciences Centre, Salford Royal Hospital Foundation Trust, Salford, Greater Manchester - UK

• Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome
  

  Om P. Mishra¹, Neha Thakur¹, Rabindra N. Mishra², Rajniti Prasad¹

  (1) Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi - India
  (2) Division of Biostatistics, Department of Community Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi - India si - India

• Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glome
  

  Marcelo A. Naves¹, Lúcio R. Requião-Moura¹, Maria F. Soares², José A. Silva-Júnior², Gianna Mastroianni-Kirsztajn¹, Vicente P. C. Teixeira³

  (1) Nephrology Division, Department of Medicine, Federal University of Sao Paulo (UNIFESP), Sao Paulo - Brazil
  (2) Department of Pathology, Federal University of Sao Paulo (UNIFESP), Sao Paulo - Brazil
  (3) Nephrology Division, Department of Medicine, Federal University of Sao Paulo (UNIFESP), Sao Paulo - Brazil and Department of Pathology, Federal University of Sao Paulo (UNIFESP), Sao Paulo - Brazil

• Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats
  

  Mehdi Nematbakhsh^1,2,3, Farzaneh Ashrafi^1,4, Tahereh Safari^1,3, Ardeshir Talebi^1,5, Hamid Nasri^1,2,6, Mojgan Mortazavi^2,6, Mehdi Khazaei³, Mohammad-Mehdi Baradaran-Mahdavi³

  (1) Kidney Basic Sciences Research Center, Isfahan University of Medical Sciences, Isfahan - Iran
  (2) Kidney diseases Research Center, Isfahan University of Medical Sciences, Isfahan - Iran
  (3) Department of Physiology, Isfahan University of Medical Sciences, Isfahan - Iran
  (4) Hematology Section, Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan - Iran
  (5) Department of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan - Iran
  (6) Nephrology Section, Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan - Iran

• Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27kip1 l
  

  Maodong Liu¹, Yanling Zhang¹, Yanqing Chi¹, Shana Zhai¹, Baoxing Wang¹, Yonghong Shi², Ying Li¹

  (1) Department of Nephrology, Third Hospital, Hebei Medical University, Shijiazhuang - PR China
  (2) Department of Pathology, Hebei Medical University, Shijiazhuang - PR China

• Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal fu
  

  Lei Meng¹, Ying Yang¹, Li-Tong Qi¹, Xue-jing Wang^2,3, Guo-Bin Xu^2,3, Bao-Wei Zhang¹

  (1) Department of Cardiology, Peking University First Hospital, Beijing - PR China
  (2) Department of Clinical Laboratory
  (3) Peking University First Hospital, Beijing - PR China

• Validation of the salivary urea test as a method to diagnose chronic kidney disease
  

  Maria E. Zúñiga¹, Luis O. Estremadoyro², Cristian P. León², Julio A. Huapaya³, Javier A. Cieza²

  (1) Department of Laboratory and Pathology, Cayetano Heredia Peruvian University, Lima - Perú
  (2) Nephrology Service, University Hospital, Cayetano Heredia Peruvian University, Lima - Perú
  (3) Scientific Society of Medical Students, Cayetano Heredia University, Lima - Perú

• A prospective, multicenter, randomized, controlled study: the Correction of Metabolic Acidosis with Use of Bicarbonate i
  

  Biagio Di Iorio¹, Filippo Aucella², Giuseppe Conte³, Adamasco Cupisti^4,5, Domenico Santoro⁶

  (1) SOC di Nefrologia, “A. Landolfi” Hospital, Solofra, Avellino - Italy and Work Group of the Conservative Therapy for Chronic Renal Insufficiency, Rome - Italy
  (2) Work Group of the Conservative Therapy for Chronic Renal Insufficiency, Rome - Italy and “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo, Foggia, Italy
  (3) Work Group of the Conservative Therapy for Chronic Renal Insufficiency, Rome - Italy and Department of Nephrology, Second University of Naples, Naples - Italy
  (4) Work Group of the Conservative Therapy for Chronic Renal Insufficiency, Rome - Italy
  (5) and Nephrology Division, Department of Internal Medicine, University of Pisa, Pisa - Italy
  (6) Work Group of the Conservative Therapy for Chronic Renal Insufficiency, Rome - Italy and Department of Nephrology, University of Messina, Messina - Italy